Skip to main content
Premium Trial:

Request an Annual Quote

Time of Preprints

With the COVID-19 pandemic, the preprint site medRxiv has taken off, writes Inside Higher Ed.

Cold Spring Harbor Laboratory, Yale University, and BMJ launched the site in 2019 with the aim of creating an arXiv- or bioXriv-like preprint server for medical and health science manuscripts. 

The site at first had a slow uptake — which IHE says its developers expected — but now, with the pandemic, its use has exploded. "In January 2020 we got 240 manuscripts," John Inglis, the co-founder of the site from the Cold Spring Harbor Laboratory Press, tells IHE. "In May of 2020 we got 2,400."

IHE notes medRxiv became stricter along the way. At first, preprints underwent screening for plagiarism and ethical lapses and could be rejected if they might cause alarm. As the pandemic progressed, IHE says it stopped, for instance, allowing papers based only on computer modeling. Still, critics say preprint servers can enable flawed papers to gain traction, but proponents note preprints can enable research to move more quickly, it adds.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more